Gut Microbiota Ecology and Inferred Functions in Children With ASD Compared to Neurotypical Subjects
Open accessThe DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.
Abstract
Autism spectrum disorders (ASDs) is a multifactorial neurodevelopmental disorder. The communication between the gastrointestinal (GI) tract and the central nervous system seems driven by gut microbiota (GM). Herein, we provide GM profiling, considering GI functional symptoms, neurological impairment, and dietary habits. Forty-one and 35 fecal samples collected from ASD and neurotypical children (CTRLs), respectively, (age range, 3–15 years) were analyzed by 16S targeted-metagenomics (the V3–V4 region) and inflammation and permeability markers (i.e., sIgA, zonulin lysozyme), and then correlated with subjects’ metadata. Our ASD cohort was characterized as follows: 30/41 (73%) with GI functional symptoms; 24/41 (58%) picky eaters (PEs), with one or more dietary needs, including 10/41 (24%) with food selectivity (FS); 36/41 (88%) presenting high and medium autism severity symptoms (HMASSs). Among the cohort with GI symptoms, 28/30 (93%) showed HMASSs, 17/30 (57%) were picky eaters and only 8/30 (27%) with food selectivity. The remaining 11/41 (27%) ASDs without GI symptoms that were characterized by HMASS for 8/11 (72%) and 7/11 (63%) were picky eaters. GM ecology was investigated for the overall ASD cohort versus CTRLs; ASDs with GI and without GI, respectively, versus CTRLs; ASD with GI versus ASD without GI; ASDs with HMASS versus low ASSs; PEs versus no-PEs; and FS versus absence of FS. In particular, the GM of ASDs, compared to CTRLs, was characterized by the increase of Proteobacteria, Bacteroidetes, Rikenellaceae, Pasteurellaceae, Klebsiella, Bacteroides, Roseburia, Lactobacillus, Prevotella, Sutterella, Staphylococcus, and Haemophilus. Moreover, Sutterella, Roseburia and Fusobacterium were associated to ASD with GI symptoms compared to CTRLs. Interestingly, ASD with GI symptoms showed higher value of zonulin and lower levels of lysozyme, which were also characterized by differentially expressed predicted functional pathways. Multiple machine learning models classified correctly 80% overall ASDs, compared with CTRLs, based on Bacteroides, Lactobacillus, Prevotella, Staphylococcus, Sutterella, and Haemophilus features. In conclusion, in our patient cohort, regardless of the evaluation of many factors potentially modulating the GM profile, the major phenotypic determinant affecting the GM was represented by GI hallmarks and patients’ age.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482
Proteobacteria: Microbial signature of dysbiosis in gut microbiota
Shin, N.-R., Whon, T. W., & Bae, J.-W. (2015) · Trends in Biotechnology · doi:10.1016/j.tibtech.2015.06.011 · Cited by 3,954 · cited 2×
“About global microbial distribution, the Pasteurellaceae family (Liu F. et al., 2019) was significantly associated with patients with Frontiers in Microbiology | www.frontiersin.org 15 June 2022 | Volume 13 | Article 871086 ASD reinforcing the idea of a link to host inflammation (Shin et al., 2015).”
BackgroundMaenner, M. J., Shaw, K. A., Baio, J., EdS1, Washington, A., Patrick, M., DiRienzo, M., Christensen, D. L., Wiggins, L. D., Pettygrove, S., et al. (2020) · MMWR. Surveillance Summaries · doi:10.15585/mmwr.ss6904a1 · Cited by 3,780 · cited 2×
“5 per 1,000 (one in 54) children aged 8 years (Maenner et al., 2020), and European studies have reported prevalence of 1 and 2% in the childhood population (Carta et al.”
BackgroundMethodInfluentialThe gut microbiota–brain axis in behaviour and brain disorders
Morais, L. H., Schreiber, H. L., & Mazmanian, S. K. (2021) · Nature Reviews Microbiology · doi:10.1038/s41579-020-00460-0 · Cited by 2,149 · cited 1×
“In addition, Bacteroidetes were predominantly associated with the patients with GI symptoms underlying autism symptoms severity, as previously reported (Morais et al., 2021).”
BackgroundRome IV—Functional GI Disorders: Disorders of Gut-Brain Interaction
Drossman, D. A., & Hasler, W. L. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.03.035 · Cited by 1,928 · cited 2×
“The GI symptoms were assessed by using the questionnaire based on Rome IV criteria (Drossman and Hasler, 2016) and specific gastroenterologists’ observations.”
MethodInteractions between the microbiota, immune and nervous systems in health and disease
Fung, T. C., Olson, C. A., & Hsiao, E. Y. (2017) · Nature Neuroscience · doi:10.1038/nn.4476 · Cited by 1,900
The interplay between the intestinal microbiota and the brain
Collins, S. M., Surette, M., & Bercik, P. (2012) · Nature Reviews Microbiology · doi:10.1038/nrmicro2876 · Cited by 1,611 · cited 1×
“Among ASD comorbidities, gastrointestinal (GI) symptoms are of particular interest, given their reported prevalence (Buie et al., 2010; Coury et al., 2012) and correlation with ASD severity (Adams et al., 2011; Chernikova et al., 2021).”
BackgroundStandardizing ADOS Scores for a Measure of Severity in Autism Spectrum Disorders
Gotham, K., Pickles, A., & Lord, C. (2009) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-008-0674-3 · Cited by 1,605 · cited 3×
“The OTU table was normalized by cumulative-sum scaling (CSS) (Paulson et al., 2013).”
MethodThe central nervous system and the gut microbiome
Sharon, G., Sampson, T. R., Geschwind, D. H., & Mazmanian, S. K. (2016) · Cell · doi:10.1016/j.cell.2016.10.027 · Cited by 1,513 · cited 1×
“Several aspects of individuals’ behavior and physiology can be affected by changes in the host genome and microbiome (Sharon et al., 2016; Vuong and Hsiao, 2017; Lynch and Hsiao, 2019; Sherwin et al., 2019), and their interactions (Fischbach and Segre, 2016); hence, it is crucial to understand…”
BackgroundGut/brain axis and the microbiota
Mayer, E. A., Tillisch, K., & Gupta, A. (2015) · Journal of Clinical Investigation · doi:10.1172/jci76304 · Cited by 1,503
Kang, D.-W., Adams, J. B., Gregory, A. C., Borody, T., Chittick, L., Fasano, A., Khoruts, A., Geis, E., Maldonado, J., McDonough-Means, S., et al. (2017) · Microbiome · doi:10.1186/s40168-016-0225-7 · Cited by 1,391
The immune response to Prevotella bacteria in chronic inflammatory disease
Larsen, J. M. (2017) · Immunology · doi:10.1111/imm.12760 · Cited by 1,343 · cited 2×
“High abundance of Prevotella spp. affects inflammation and mucosal and systemic T cell stimulation (Larsen, 2017; Iljazovic et al., 2021).”
BackgroundSecretory IgA's complex roles in immunity and mucosal homeostasis in the gut
Mantis, N. J., Rol, N., & Corthésy, B. (2011) · Mucosal Immunology · doi:10.1038/mi.2011.41 · Cited by 1,283 · cited 2×
“…IgAs (sIgAs) represent the first immune barrier of defense in the gut protecting the intestinal epithelium from pathogens and enteric toxins (Mantis et al., 2011), hence mediating the innate immune defense mechanism at the level of the gut mucosa, as also reported in patients Frontiers in…”
BackgroundMicrobiota and neurodevelopmental windows: implications for brain disorders
Borre, Y. E., O’Keeffe, G. W., Clarke, G., Stanton, C., Dinan, T. G., & Cryan, J. F. (2014) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2014.05.002 · Cited by 1,089
Adams, J. B., Johansen, L. J., Powell, L. D., Quig, D., & Rubin, R. A. (2011) · BMC Gastroenterology · doi:10.1186/1471-230x-11-22 · Cited by 1,076 · cited 7×
“Elevated levels of fecal lysozyme have been identified in colonic IBD when compared to healthy controls (Klass and Neale, 1978; Veer et al., 1998) but also in patients with ASD (Adams et al., 2011).”
BackgroundResultInfluentialPsychobiotics and the manipulation of bacteria–gut–brain signals
Sarkar, A., Lehto, S. M., Harty, S., Dinan, T. G., Cryan, J. F., & Burnet, P. W. J. (2016) · Trends in Neurosciences · doi:10.1016/j.tins.2016.09.002 · Cited by 1,068
The Changing Epidemiology of Autism Spectrum Disorders
Lyall, K., Croen, L., Daniels, J., Fallin, M. D., Ladd-Acosta, C., Lee, B. K., Park, B. Y., Snyder, N. W., Schendel, D., Volk, H., et al. (2017) · Annual Review of Public Health · doi:10.1146/annurev-publhealth-031816-044318 · Cited by 1,011
Pyrosequencing study of fecal microflora of autistic and control children
Finegold, S. M., Dowd, S. E., Gontcharova, V., Liu, C., Henley, K. E., Wolcott, R. D., Youn, E., Summanen, P. H., Granpeesheh, D., Dixon, D., et al. (2010) · Anaerobe · doi:10.1016/j.anaerobe.2010.06.008 · Cited by 977
Reduced incidence of Prevotella and other fermenters in intestinal microflora of autistic children
Kang, D.-W., Park, J. G., Ilhan, Z. E., Wallstrom, G., LaBaer, J., Adams, J. B., & Krajmalnik-Brown, R. (2013) · PLoS ONE · doi:10.1371/journal.pone.0068322 · Cited by 976 · cited 1×
“Also, presence or absence of GERD (Wasilewska and Klukowski, 2015) and colonic eosinophilia (Katzka, 2014) from intestinal biopsies was considered when available.”
BackgroundDe Angelis, M., Piccolo, M., Vannini, L., Siragusa, S., De Giacomo, A., Serrazzanetti, D. I., Cristofori, F., Guerzoni, M. E., Gobbetti, M., & Francavilla, R. (2013) · PLoS ONE · doi:10.1371/journal.pone.0076993 · Cited by 887 · cited 2×
“Moreover, Roseburia has a low capacity to degrade free amino acids (FAAs) at the gut level and, because, in ASD, the especially increased FAA has been described to be glutamate, probably its increase is related to high concentration of Roseburia (De Angelis et al., 2013).”
BackgroundBuie, T., Campbell, D. B., Fuchs, G. J., Furuta, G. T., Levy, J., VandeWater, J., Whitaker, A. H., Atkins, D., Bauman, M. L., Beaudet, A. L., et al. (2010) · Pediatrics · doi:10.1542/peds.2009-1878c · Cited by 872 · cited 3×
“The obtained raw reads were analyzed using Quantitative Insights into Microbial Ecology software (QIIME, 1.9.1) (Caporaso et al., 2010) to perform demultiplexing, quality score checking, low length exclusion, and denoising.”
MethodInfluentialParracho, H. M., Bingham, M. O., Gibson, G. R., & McCartney, A. L. (2005) · Journal of Medical Microbiology · doi:10.1099/jmm.0.46101-0 · Cited by 784 · cited 1×
“…many studies have highlighted the role of the gut microbiota (GM) in neurodevelopmental disorders (Hsiao et al., 2013; Borre et al., 2014; Kelly et al., 2017), particularly in ASD (Parracho et al., 2005; Finegold et al., 2010; Adams et al., 2011; Williams et al., 2011, 2012; Kang et al., 2013).”
BackgroundAutistic-like social behaviour in Shank2-mutant mice improved by restoring NMDA receptor function
Won, H., Lee, H.-R., Gee, H. Y., Mah, W., Kim, J.-I., Lee, J., Ha, S., Chung, C., Jung, E. S., Cho, Y. S., et al. (2012) · Nature · doi:10.1038/nature11208 · Cited by 695 · cited 1×
“Indeed, glutamate acts as neurotransmitters in the CNS, and, since it is a potent neurotoxin, an excess could lead to neuronal death, as reported in neuropsychiatric disorders pathophysiology, including autism (Won et al., 2012; Yang and Chang, 2014).”
BackgroundGastrointestinal microbiota in children with autism in Slovakia
Tomova, A., Husarova, V., Lakatosova, S., Bakos, J., Vlkova, B., Babinska, K., & Ostatnikova, D. (2015) · Physiology & Behavior · doi:10.1016/j.physbeh.2014.10.033 · Cited by 632 · cited 1×
“…Ma et al., 2019; Berding and Donovan, 2020) have highlighted specific overrepresented ASD-related microbial signatures, such as Ruminococcus, Sutterella, Enterococcus, Prevotella, and Fecalibacterium prausnitzii (Kang et al., 2013; De Angelis et al., 2015; Tomova et al., 2015; Fung et al., 2017).”
BackgroundLeblond, C. S., Nava, C., Polge, A., Gauthier, J., Huguet, G., Lumbroso, S., Giuliano, F., Stordeur, C., Depienne, C., Mouzat, K., et al. (2014) · PLoS Genetics · doi:10.1371/journal.pgen.1004580 · Cited by 630
DSM-Oriented and empirically based approaches to constructing scales from the same item pools
Achenbach, T. M., Dumenci, L., & Rescorla, L. A. (2003) · Journal of Clinical Child & Adolescent Psychology · doi:10.1207/s15374424jccp3203_02 · Cited by 615 · cited 1×
“According to the cut-off thresholds of Achenbach et al. (2003), Internalizing, Externalizing, and Total Problems’ scales were classified according to symptoms’ t-scores: clinically relevant (≥65), borderline (60–64), and non-clinical Frontiers in Microbiology | www.frontiersin.org 3 June 2022 |…”
MethodEmerging Roles for the Gut Microbiome in Autism Spectrum Disorder
Vuong, H. E., & Hsiao, E. Y. (2017) · Biological Psychiatry · doi:10.1016/j.biopsych.2016.08.024 · Cited by 595 · cited 2×
“Several aspects of individuals’ behavior and physiology can be affected by changes in the host genome and microbiome (Sharon et al., 2016; Vuong and Hsiao, 2017; Lynch and Hsiao, 2019; Sherwin et al., 2019), and their interactions (Fischbach and Segre, 2016); hence, it is crucial to understand…”
BackgroundGastrointestinal Problems in Children with Autism, Developmental Delays or Typical Development
Chaidez, V., Hansen, R. L., & Hertz-Picciotto, I. (2014) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-013-1973-x · Cited by 528
Sturgeon, C., & Fasano, A. (2016) · Tissue Barriers · doi:10.1080/21688370.2016.1251384 · Cited by 497
Blood–brain barrier and intestinal epithelial barrier alterations in autism spectrum disorders
Fiorentino, M., Sapone, A., Senger, S., Camhi, S. S., Kadzielski, S. M., Buie, T. M., Kelly, D. L., Cascella, N., & Fasano, A. (2016) · Molecular Autism · doi:10.1186/s13229-016-0110-z · Cited by 494 · cited 2×
“The zonulin is involved in the intestinal permeability regulation and has been reported as reducing the expression of barrier components in the tight junctions in 75% of the patients with ASD (Fiorentino et al., 2016; Özyurt et al., 2018).”
BackgroundWilliams, B. L., Hornig, M., Buie, T., Bauman, M. L., Cho Paik, M., Wick, I., Bennett, A., Jabado, O., Hirschberg, D. L., & Lipkin, W. I. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024585 · Cited by 492 · cited 1×
“…many studies have highlighted the role of the gut microbiota (GM) in neurodevelopmental disorders (Hsiao et al., 2013; Borre et al., 2014; Kelly et al., 2017), particularly in ASD (Parracho et al., 2005; Finegold et al., 2010; Adams et al., 2011; Williams et al., 2011, 2012; Kang et al., 2013).”
BackgroundMicrobiota and the social brain
Sherwin, E., Bordenstein, S. R., Quinn, J. L., Dinan, T. G., & Cryan, J. F. (2019) · Science · doi:10.1126/science.aar2016 · Cited by 462 · cited 2×
“…and physiology can be affected by changes in the host genome and microbiome (Sharon et al., 2016; Vuong and Hsiao, 2017; Lynch and Hsiao, 2019; Sherwin et al., 2019), and their interactions (Fischbach and Segre, 2016); hence, it is crucial to understand whether ASD symptoms are influenced by…”
BackgroundAltered gut microbiota and short chain fatty acids in Chinese children with autism spectrum disorder
Liu, S., Li, E., Sun, Z., Fu, D., Duan, G., Jiang, M., Yu, Y., Mei, L., Yang, P., Tang, Y., et al. (2019) · Scientific Reports · doi:10.1038/s41598-018-36430-z · Cited by 457
Mazurek, M. O., Vasa, R. A., Kalb, L. G., Kanne, S. M., Rosenberg, D., Keefer, A., Murray, D. S., Freedman, B., & Lowery, L. A. (2013) · Journal of Abnormal Child Psychology · doi:10.1007/s10802-012-9668-x · Cited by 419
Intestinal permeability and its regulation by zonulin: Diagnostic and therapeutic implications
Fasano, A. (2012) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2012.08.012 · Cited by 402
The Possible Role of the Microbiota-Gut-Brain-Axis in Autism Spectrum Disorder
Srikantha, P., & Mohajeri, M. H. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20092115 · Cited by 400 · cited 1×
“Particularly, concentrations of propionic acid produced by Bacteroides may play beneficial effects for the enterocytes despite of high concentrations may be related to toxic effects (Frye et al., 2016; Srikantha and Mohajeri, 2019).”
BackgroundWilliams, B. L., Hornig, M., Parekh, T., & Lipkin, W. I. (2012) · mBio · doi:10.1128/mbio.00261-11 · Cited by 378 · cited 2×
“…many studies have highlighted the role of the gut microbiota (GM) in neurodevelopmental disorders (Hsiao et al., 2013; Borre et al., 2014; Kelly et al., 2017), particularly in ASD (Parracho et al., 2005; Finegold et al., 2010; Adams et al., 2011; Williams et al., 2011, 2012; Kang et al., 2013).”
BackgroundResultHerbert, M. R. (2010) · Current Opinion in Neurology · doi:10.1097/wco.0b013e328336a01f · Cited by 356 · cited 1×
“However, ASD is an etiologically heterogeneous disorder involving multiple factors, such as genetic (Jonsson et al., 2014; Leblond et al., 2014; Wilkinson et al., 2015) and environmental factors (Herbert, 2010; Raz et al., 2015), including pre- and/or post-natal factors (de Theije et al., 2011).”
BackgroundMicrobiomes as sources of emergent host phenotypes
Lynch, J. B., & Hsiao, E. Y. (2019) · Science · doi:10.1126/science.aay0240 · Cited by 339 · cited 2×
“…of individuals’ behavior and physiology can be affected by changes in the host genome and microbiome (Sharon et al., 2016; Vuong and Hsiao, 2017; Lynch and Hsiao, 2019; Sherwin et al., 2019), and their interactions (Fischbach and Segre, 2016); hence, it is crucial to understand whether ASD…”
BackgroundLiu, F., Li, J., Wu, F., Zheng, H., Peng, Q., & Zhou, H. (2019) · Translational Psychiatry · doi:10.1038/s41398-019-0389-6 · Cited by 336
Gastrointestinal dysfunction in autism: parental report, clinical evaluation, and associated factors
Gorrindo, P., Williams, K. C., Lee, E. B., Walker, L. S., McGrew, S. G., & Levitt, P. (2012) · Autism Research · doi:10.1002/aur.237 · Cited by 325 · cited 1×
“…et al., 2017), increased sensory sensitivity (Mazurek et al., 2013), and sleep problems (Horvath and Perman, 2002; Maenner et al., 2012) have been reported in patients with ASD in presence/absence of GI symptoms (Adams et al., 2011; Wang et al., 2011; Gorrindo et al., 2012; Chaidez et al., 2014).”
BackgroundAutism spectrum disorders and intestinal microbiota
De Angelis, M., Francavilla, R., Piccolo, M., De Giacomo, A., & Gobbetti, M. (2015) · Gut Microbes · doi:10.1080/19490976.2015.1035855 · Cited by 311
VALICENTI-McDERMOTT, M., McVICAR, K., RAPIN, I., WERSHIL, B. K., COHEN, H., & SHINNAR, S. (2006) · Journal of Developmental & Behavioral Pediatrics · doi:10.1097/00004703-200604002-00011 · Cited by 302 · cited 2×
“GI symptoms include abdominal pain, constipation, diarrhea, bloating, and gastroesophageal reflux (GERD) (Horvath and Perman, 2002; Valicenti-McDermott et al., 2006; Nikolov et al., 2009).”
BackgroundHolingue, C., Newill, C., Lee, L., Pasricha, P. J., & Daniele Fallin, M. (2018) · Autism Research · doi:10.1002/aur.1854 · Cited by 296 · cited 1×
“Typical ASD profiles, associated with GI symptoms and behavior indices, may be correlated with ASD severity (Holingue et al., 2018), hence suggesting that the communication between gut-brain axis and nutritional altered habits may be involved in ASD pathogenesis (Mayer et al., 2015; Beaudet, 2017).”
BackgroundLordan, C., Thapa, D., Ross, R. P., & Cotter, P. D. (2020) · Gut Microbes · doi:10.1080/19490976.2019.1613124 · Cited by 289 · cited 2×
“Worth noting is that the statistically significant presence of Ruminococcus in ASD without GI symptoms may corroborate the idea that a starch-degrading bacterium (Lordan et al., 2020) could improve the GI wellness, preserving from symptoms, more responding to nutritional triggers rather than to host innate immunity (Y…”
BackgroundGastrointestinal Conditions in Children With Autism Spectrum Disorder: Developing a Research Agenda
Coury, D. L., Ashwood, P., Fasano, A., Fuchs, G., Geraghty, M., Kaul, A., Mawe, G., Patterson, P., & Jones, N. E. (2012) · Pediatrics · doi:10.1542/peds.2012-0900n · Cited by 264 · cited 1×
“Among ASD comorbidities, gastrointestinal (GI) symptoms are of particular interest, given their reported prevalence (Buie et al., 2010; Coury et al., 2012) and correlation with ASD severity (Adams et al., 2011; Chernikova et al., 2021).”
BackgroundWang, L. W., Tancredi, D. J., & Thomas, D. W. (2011) · Journal of Developmental & Behavioral Pediatrics · doi:10.1097/dbp.0b013e31821bd06a · Cited by 258
Gastrointestinal symptoms in a sample of children with pervasive developmental disorders
Nikolov, R. N., Bearss, K. E., Lettinga, J., Erickson, C., Rodowski, M., Aman, M. G., McCracken, J. T., McDougle, C. J., Tierney, E., Vitiello, B., et al. (2009) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-008-0637-8 · Cited by 240
Rose, D. R., Yang, H., Serena, G., Sturgeon, C., Ma, B., Careaga, M., Hughes, H. K., Angkustsiri, K., Rose, M., Hertz-Picciotto, I., et al. (2018) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2018.03.025 · Cited by 227 · cited 1×
“However, Rose et al. (2018) observed no changes in zonulin levels in ASDs with no statistically significant over-expression of the HP2 gene product in the patients with ASD, but only a significant difference between ASD with GI symptoms and typically developing children with GI symptoms.”
BackgroundAutistic disorder and gastrointestinal disease
Horvath, K., & Perman, J. A. (2002) · Current Opinion in Pediatrics · doi:10.1097/00008480-200210000-00004 · Cited by 224 · cited 3×
“GI symptoms include abdominal pain, constipation, diarrhea, bloating, and gastroesophageal reflux (GERD) (Horvath and Perman, 2002; Valicenti-McDermott et al., 2006; Nikolov et al., 2009).”
BackgroundAutism, Gastrointestinal Symptoms and Modulation of Gut Microbiota by Nutritional Interventions
Ristori, M. V., Quagliariello, A., Reddel, S., Ianiro, G., Vicari, S., Gasbarrini, A., & Putignani, L. (2019) · Nutrients · doi:10.3390/nu11112812 · Cited by 214
Self-citationGastrointestinal symptoms and behavioral problems in preschoolers with Autism Spectrum Disorder
Fulceri, F., Morelli, M., Santocchi, E., Cena, H., Del Bianco, T., Narzisi, A., Calderoni, S., & Muratori, F. (2016) · Digestive and Liver Disease · doi:10.1016/j.dld.2015.11.026 · Cited by 191 · cited 1×
“Among neurological symptoms, irritability (Bresnahan et al., 2015), anxiety and affective disorders (Valicenti-McDermott et al., 2006; Fulceri et al., 2016), dysregulation and externalizing problems (Horvath and Perman, 2002), rigid/compulsive behaviors (Peters et al., 2014; Marler et al., 2017),…”
BackgroundGut microbiome composition is associated with temperament during early childhood
Christian, L. M., Galley, J. D., Hade, E. M., Schoppe-Sullivan, S., Kamp Dush, C., & Bailey, M. T. (2015) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2014.10.018 · Cited by 191
Bresnahan, M., Hornig, M., Schultz, A. F., Gunnes, N., Hirtz, D., Lie, K. K., Magnus, P., Reichborn-Kjennerud, T., Roth, C., Schjølberg, S., et al. (2015) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2014.3034 · Cited by 132
Frye, R. E., Rose, S., Chacko, J., Wynne, R., Bennuri, S. C., Slattery, J. C., Tippett, M., Delhey, L., Melnyk, S., Kahler, S. G., et al. (2016) · Translational Psychiatry · doi:10.1038/tp.2016.189 · Cited by 130
Maenner, M. J., Arneson, C. L., Levy, S. E., Kirby, R. S., Nicholas, J. S., & Durkin, M. S. (2012) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-011-1379-6 · Cited by 122 · cited 2×
“, 2013), and sleep problems (Horvath and Perman, 2002; Maenner et al., 2012) have been reported in patients with ASD in presence/absence of GI symptoms (Adams et al.”
BackgroundAssociation of rigid-compulsive behavior with functional constipation in autism spectrum disorder
Marler, S., Ferguson, B. J., Lee, E. B., Peters, B., Williams, K. C., McDonnell, E., Macklin, E. A., Levitt, P., Margolis, K. G., Beversdorf, D. Q., et al. (2017) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-017-3084-6 · Cited by 94
Rose, S., Bennuri, S. C., Murray, K. F., Buie, T., Winter, H., & Frye, R. E. (2017) · PLOS ONE · doi:10.1371/journal.pone.0186377 · Cited by 82 · cited 2×
“Hence, SCFAs could disrupt cellular physiology to cause functional GI disease related to ASD, such as dismotility and non-specific inflammation (Kang et al., 2017; Rose et al., 2017).”
BackgroundFlannery, J. E., Stagaman, K., Burns, A. R., Hickey, R. J., Roos, L. E., Giuliano, R. J., Fisher, P. A., & Sharpton, T. J. (2020) · mBio · doi:10.1128/mbio.02780-19 · Cited by 75
Hashemi, Z., Fouhse, J., Im, H., Chan, C., & Willing, B. (2017) · Nutrients · doi:10.3390/nu9111236 · Cited by 70 · cited 1×
“…decreased in all the ASD subjects regardless of presence or absence of GI symptoms, compared to CTRLs, thus reducing its protection activity against gut inflammation and cooperating in the development of the immune system (Medina et al., 2008; Salazar et al., 2008; Hashemi et al., 2017).”
BackgroundRigid-compulsive behaviors are associated with mixed bowel symptoms in autism spectrum disorder
Peters, B., Williams, K. C., Gorrindo, P., Rosenberg, D., Lee, E. B., Levitt, P., & Veenstra-VanderWeele, J. (2014) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-013-2009-2 · Cited by 70 · cited 1×
“…et al., 2006; Fulceri et al., 2016), dysregulation and externalizing problems (Horvath and Perman, 2002), rigid/compulsive behaviors (Peters et al., 2014; Marler et al., 2017), increased sensory sensitivity (Mazurek et al., 2013), and sleep problems (Horvath and Perman, 2002;…”
Background
Cited by
Key determinants of success in fecal microbiota transplantation: From microbiome to clinic
Porcari, S., Benech, N., Valles-Colomer, M., Segata, N., Gasbarrini, A., Cammarota, G., Sokol, H., & Ianiro, G. (2023) · Cell Host & Microbe · doi:10.1016/j.chom.2023.03.020 · Cited by 331
Self-citationHung, L. Y., & Margolis, K. G. (2024) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-023-00857-1 · Cited by 96
Patterns of Food Selectivity among Children with Autism Spectrum Disorders
Byrska, A., Błażejczyk, I., Faruga, A., Potaczek, M., Wilczyński, K. M., & Janas-Kozik, M. (2023) · doi:10.20944/preprints202307.0875.v1 · Cited by 37
“, the number and type of bacteria that are common to different individuals [32], is similar in children with and without ASD, but it was found that Dichelobacter, Nitriliruptor, and Constrictibacter may be probable markers of ASD.”
Background
Metadata
- Authors
- Vernocchi, P., Ristori, M. V., Guerrera, S., Guarrasi, V., Conte, F., Russo, A., Lupi, E., Albitar-Nehme, S., Gardini, S., Paci, P., Ianiro, G., Vicari, S., Gasbarrini, A., & Putignani, L.
- Venue
- Frontiers in Microbiology
- Publisher
- Frontiers Media SA
- Published
- 2022-06-09
- Volume
- 13
- Pages
- 871086-871086
- ISSN
- 1664-302X (ISSN-L)
- OpenAlex
- W4285744466
- Cited by
- 44
- References
- 61
- FWCI
- 2.35
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.